Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1988 Jul;43(7):516–524. doi: 10.1136/thx.43.7.516

Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.

D Valeyre 1, P Soler 1, C Clerici 1, J Pré 1, J P Battesti 1, R Georges 1, A J Hance 1
PMCID: PMC461354  PMID: 2850637

Abstract

Patients with pulmonary sarcoidosis are less likely to smoke than persons of a similar age in the general population. This could be because smoking reduces the likelihood of developing sarcoidosis, or alternatively smoking could reduce the severity of the disease process so that smoking patients are underrepresented among patients with clinically overt disease. To evaluate these possibilities 64 patients with sarcoidosis of recent onset were studied at presentation and after a one year follow up period, clinical, functional, radiographic, and bronchoalveolar lavage fluid criteria being used to identify factors that might account for the lower incidence of sarcoidosis in smokers and to determine whether the disease is less severe in smoking patients. Smoking was less common in the patients with sarcoidosis (30%) than in the control subjects (46%). The study did not support the conclusion that sarcoidosis is less severe in smokers, as clinical, radiographic, and functional abnormalities were similar in smokers and non-smokers at initial evaluation and after a one year follow up period. Nevertheless, smoking did influence various indices used to assess disease "activity." Cigarette smoking was associated with a significant increase in the serum angiotensin converting enzyme activity (SACE), and patients with very high SACE and pulmonary gallium-67 uptake were smokers. Furthermore, more CD8+ (but not CD4+) lymphocytes were recovered by lavage from smoking than from non-smoking patients, giving a lower CD4: CD8 ratio in smokers. Fewer alveolar macrophages were recovered by lavage from smokers with sarcoidosis than from normal subjects with a similar smoking history. These finding support the possibility that smokers, particularly those with a prominent accumulation of alveolar macrophages in the lower respiratory tract, may be less likely to develop sarcoidosis.

Full text

PDF
516

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. S., Gacad M. A., Anders A., Endres D. B., Sharma O. P. Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis. Sarcoidosis. 1986 Mar;3(1):1–6. [PubMed] [Google Scholar]
  2. BLAKEMORE W. S., FORSTER R. E., MORTON J. W., OGILVIE C. M. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957 Jan;36(1 Pt 1):1–17. doi: 10.1172/JCI103402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bisson G., Drapeau G., Lamoureux G., Cantin A., Rola-Pleszczynski M., Bégin R. Computer-based quantitative analysis of gallium-67 uptake in normal and diseased lungs. Chest. 1983 Nov;84(5):513–517. doi: 10.1378/chest.84.5.513. [DOI] [PubMed] [Google Scholar]
  4. Bresnitz E. A., Strom B. L. Epidemiology of sarcoidosis. Epidemiol Rev. 1983;5:124–156. doi: 10.1093/oxfordjournals.epirev.a036255. [DOI] [PubMed] [Google Scholar]
  5. Crystal R. G., Bitterman P. B., Rennard S. I., Hance A. J., Keogh B. A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med. 1984 Jan 19;310(3):154–166. doi: 10.1056/NEJM198401193100304. [DOI] [PubMed] [Google Scholar]
  6. Daniele R. P., Dauber J. H., Altose M. D., Rowlands D. T., Jr, Gorenberg D. J. Lymphocyte studies in asymptomatic cigarette smokers. A comparison between lung and peripheral blood. Am Rev Respir Dis. 1977 Dec;116(6):997–1005. doi: 10.1164/arrd.1977.116.6.997. [DOI] [PubMed] [Google Scholar]
  7. Dauber J. H., Rossman M. D., Daniele R. P. Bronchoalveolar cell populations in acute sarcoidosis. Observations in smoking and nonsmoking patients. J Lab Clin Med. 1979 Dec;94(6):862–871. [PubMed] [Google Scholar]
  8. Douglas J. G., Middleton W. G., Gaddie J., Petrie G. R., Choo-Kang Y. F., Prescott R. J., Crompton G. K. Sarcoidosis: a disorder commoner in non-smokers? Thorax. 1986 Oct;41(10):787–791. doi: 10.1136/thx.41.10.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dutton R. E., Renzi P. M., Lopez-Majano V., Renzi G. D. Airway function in sarcoidosis: smokers versus nonsmokers. Respiration. 1982;43(3):164–173. doi: 10.1159/000194481. [DOI] [PubMed] [Google Scholar]
  10. Ettensohn D. B., Lalor P. A., Roberts N. J., Jr Human alveolar macrophage regulation of lymphocyte proliferation. Am Rev Respir Dis. 1986 Jun;133(6):1091–1096. doi: 10.1164/arrd.1986.133.6.1091. [DOI] [PubMed] [Google Scholar]
  11. Georges R., Saumon G., Loiseau A. The relationship of age to pulmonary membrane conductance and capillary blood volume. Am Rev Respir Dis. 1978 Jun;117(6):1069–1078. doi: 10.1164/arrd.1978.117.6.1069. [DOI] [PubMed] [Google Scholar]
  12. Grönhagen-Riska C. Angiotensin-converting enzyme. I. Activity and correlation with serum lysozyme in sarcoidosis, other chest or lymph node diseases and healthy persons. Scand J Respir Dis. 1979 Apr;60(2):83–93. [PubMed] [Google Scholar]
  13. Hance A. J., Basset F., Saumon G., Danel C., Valeyre D., Battesti J. P., Chrétien J., Georges R. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci. 1986;465:643–656. doi: 10.1111/j.1749-6632.1986.tb18541.x. [DOI] [PubMed] [Google Scholar]
  14. Hance A. J., Douches S., Winchester R. J., Ferrans V. J., Crystal R. G. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J Immunol. 1985 Jan;134(1):284–292. [PubMed] [Google Scholar]
  15. Harf R. A., Ethevenaux C., Gleize J., Perrin-Fayolle M., Guerin J. C., Ollagnier C. Reduced prevalence of smokers in sarcoidosis. Results of a case-control study. Ann N Y Acad Sci. 1986;465:625–631. doi: 10.1111/j.1749-6632.1986.tb18539.x. [DOI] [PubMed] [Google Scholar]
  16. Hinman L. M., Stevens C., Matthay R. A., Bernard J., Gee L. Angiotensin convertase activities in human alveolar macrophages: effects of cigarette smoking and sarcoidosis. Science. 1979 Jul 13;205(4402):202–203. doi: 10.1126/science.221980. [DOI] [PubMed] [Google Scholar]
  17. Holt P. G. Immune and inflammatory function in cigarette smokers. Thorax. 1987 Apr;42(4):241–249. doi: 10.1136/thx.42.4.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hunninghake G. W., Gadek J. E., Kawanami O., Ferrans V. J., Crystal R. G. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol. 1979 Oct;97(1):149–206. [PMC free article] [PubMed] [Google Scholar]
  19. Line B. R., Hunninghake G. W., Keogh B. A., Jones A. E., Johnston G. S., Crystal R. G. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):440–446. doi: 10.1164/arrd.1981.123.4.440. [DOI] [PubMed] [Google Scholar]
  20. Liu M. C., Proud D., Schleimer R. P., Plaut M. Human lung macrophages enhance and inhibit lymphocyte proliferation. J Immunol. 1984 Jun;132(6):2895–2903. [PubMed] [Google Scholar]
  21. Mordelet-Dambrine M. S., Stanislas-Leguern G. M., Huchon G. J., Baumann F. C., Marsac J. H., Chrétien J. Elevation of the bronchoalveolar concentration of angiotensin I converting enzyme in sarcoidosis. Am Rev Respir Dis. 1982 Sep;126(3):472–475. doi: 10.1164/arrd.1982.126.3.472. [DOI] [PubMed] [Google Scholar]
  22. Reynolds H. Y. Bronchoalveolar lavage. Am Rev Respir Dis. 1987 Jan;135(1):250–263. doi: 10.1164/arrd.1987.135.1.250. [DOI] [PubMed] [Google Scholar]
  23. Rich E. A., Tweardy D. J., Fujiwara H., Ellner J. J. Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis. 1987 Aug;136(2):258–265. doi: 10.1164/ajrccm/136.2.258. [DOI] [PubMed] [Google Scholar]
  24. Rosen Y., Athanassiades T. J., Moon S., Lyons H. A. Nongranulomatous interstitial pneumonitis in sarcoidosis. Relationship to development of epithelioid granulomas. Chest. 1978 Aug;74(2):122–125. doi: 10.1378/chest.74.2.122. [DOI] [PubMed] [Google Scholar]
  25. Siltzbach L. E., James D. G., Neville E., Turiaf J., Battesti J. P., Sharma O. P., Hosoda Y., Mikami R., Odaka M. Course and prognosis of sarcoidosis around the world. Am J Med. 1974 Dec;57(6):847–852. doi: 10.1016/0002-9343(74)90160-0. [DOI] [PubMed] [Google Scholar]
  26. Smiéjan J. M., Cosnes J., Chollet-Martin S., Soler P., Basset F. M., Le Quintrec Y., Hance A. J. Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn's disease. Ann Intern Med. 1986 Jan;104(1):17–21. doi: 10.7326/0003-4819-104-1-17. [DOI] [PubMed] [Google Scholar]
  27. Terris M., Chaves A. D. An epidemiologic study of sarcoidosis. Am Rev Respir Dis. 1966 Jul;94(1):50–55. doi: 10.1164/arrd.1966.94.1.50. [DOI] [PubMed] [Google Scholar]
  28. Thomas P. D., Hunninghake G. W. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis. 1987 Mar;135(3):747–760. doi: 10.1164/arrd.1987.135.3.747. [DOI] [PubMed] [Google Scholar]
  29. Valeyre D., Saumon G., Bladier D., Amouroux J., Pré J., Battesti J. P., Georges R. The relationships between noninvasive explorations in pulmonary sarcoidosis of recent origin, as shown in bronchoalveolar lavage, serum, and pulmonary function tests. Am Rev Respir Dis. 1982 Jul;126(1):41–45. doi: 10.1164/arrd.1982.126.1.41. [DOI] [PubMed] [Google Scholar]
  30. Warren C. P. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax. 1977 Oct;32(5):567–569. doi: 10.1136/thx.32.5.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yeager H., Jr, Williams M. C., Beekman J. F., Bayly T. C., Beaman B. L. Sarcoidosis: analysis of cells obtained by bronchial lavage. Am Rev Respir Dis. 1977 Nov;116(5):951–954. doi: 10.1164/arrd.1977.116.5.951. [DOI] [PubMed] [Google Scholar]
  32. deShazo R. D., Banks D. E., Diem J. E., Nordberg J. A., Baser Y., Bevier D., Salvaggio J. E. Bronchoalveolar lavage cell--lymphocyte interactions in normal nonsmokers and smokers. Analysis with a novel system. Am Rev Respir Dis. 1983 May;127(5):545–548. doi: 10.1164/arrd.1983.127.5.545. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES